FDA inspection
Qidong Dongyue Pharmaceutical Co. Ltd.: FDA inspection ending Aug 16, 2024
FDA inspection 1249419 · No Action Indicated (NAI) · Qidong
Key facts
| Inspection ID | 1249419 |
|---|---|
| Firm | Qidong Dongyue Pharmaceutical Co. Ltd. |
| FEI number | 3003969382 |
| Address | Binjiang Fine Chemical, No. 268 Shanghai Road; Industry Zone |
| City | Qidong |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Aug 16, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data